Single lot of dextroamphetamine (Zenzedi) recalled due to package mislabeling

Azurity Pharmaceuticals is voluntarily recalling one lot of dextroamphetamine sulfate (Zenzedi) 30 mg, following a report from a pharmacist in Nebraska who opened a bottle of Zenzedi 30 mg tablets and found tablets of carbinoxamine maleate, an antihistamine. Patients who take carbinoxamine instead of dextroamphetamine will experience undertreatment of their ADHD symptoms, which may result in functional impairment and an increased risk of accidents or injury. The manufacturer has opened a product complaint and is investigating the issue.